Autoimmunity to Type VII Collagen: Epidermolysis Bullosa Acquisita

Woodley DT et al (1984) Identification of the skin basement membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 310:1007

Woodley DT et al (1988) The epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 81:683

Woodley DT, Ram R, Doostan A, Bandyopadhyay P, Huang Y, Remington J, Hou YP, Keene DR, Liu Z, Chen M (2006) Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol 126:1324–1330

Roenigk HH et al (1971) Epidermolysis bullosa acquisita: report of three cases and review of all published cases. Arch Dermatol 103:10

Kushniruk W (1973) The immunopathology of epidermolysis bullosa acquisita. Can Med Assoc J 108:1143

Gibbs RB, Minus HR (1975) Epidermolysis bullosa acquisita with electron microscopical studies. Arch Dermatol 111:215

Yaoita H et al (1981) Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol 76:288

Briggaman RA, Wheeler CE Jr (1975) The epidermal–dermal junction. J Invest Dermatol 65:71

Keene DR et al (1987) Type VII collagen forms an extended network of anchoring fibrils. J Cell Biol 104:611

Ray TL et al (1982) Epidermolysis bullosa acquisita and inflammatory bowel disease. J Am Acad Dermatol 6:242

Bruckner-Tuderman L, Nilssen O, Zimmermann DR, Dours-Zimmermann MT, Kalinke DU, Gedde-Dahl T Jr, Winberg JO (1995) Immunohistochemical and mutation analyzes demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. J Cell Biol 131:551–559

Christiano AM, Greenspan DS, Lee S, Uitto J (1994) Cloning of human type VII collagen: complete primary sequence of the alpha 1(VII) chain and identification of intragenic polymorphisms. J Biol Chem 269:20256–20262

Chen M et al (1997) Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. J Biol Chem 272:14516

Bauer EA, Eisen AZ (1978) Recessive dystrophic epidermolysis bullosa: evidence for increased collagenase as a genetic characteristic in cell culture. J Exp Med 148:1378

Lapiere J-C et al (1993) Epitope mapping of type VII collagen: identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 92:1831

Jones DA et al (1995) Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the non-collagenous (NC1) domain. J Invest Dermatol 104:231

Woodley DT et al (1987) Specific affinity between fibronectin and the epidermolysis bullosa acquisita antigen. J Clin Invest 179:1826

Park SB, Cho KH, Youn JL, Hwang DH, Kim SC, Chung JH (1997) Epidermolysis bullosa acquisita in childhood—a case mimicking chronic bullous dermatosis of childhood. Clin Exp Dermatol 22:220–222

Callot-Mellot C, Bodemer C, Caux F, Bourgault-Villada I, Fraitag S, Goudie G, Heller M, de Prost Y, Prost C (1997) Epidermolysis bullosa acquisita in childhood. Arch Dermatol 133:1122–1126

Lapiere J-C et al (1994) Type VII collagen specifically binds fibronectin via a unique subdomain within the collagenous triple helix. J Invest Dermatol 103:637

Chen M, Keene DR, Costa FK, Tahk SH, Woodley DT (2001) The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis bullosa acquisita autoantibodies. J Biol Chem 276:21649–21655

Gammon WR et al (1984) Epidermolysis bullosa acquisita: a pemphigoid-like disease. J Am Acad Dermatol 11:820

Woodley DT, Chang C, Saadat P, Ram R, Liu Z, Chen M (2005) Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 124:958–964

Sitaru C, Mihai S, Otto C, Chiriac MT, Hausser I, Dotterweich B, Saito H, Rose C, Ishiko A, Zillikens D (2005) Induction of dermal–epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 115:870–878

Kurzhals G et al (1991) Acquired epidermolysis bullosa with the clinical features of Brunsting–Perry cicatricial bullous pemphigoid. Arch Dermatol 127:391

Hashimoto T, Ishiko A, Shimizu H, Tanaka T, Dodd HJ, Bhogal BS, Black MM, Nishikawa T (1996) A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies. Br J Dermatol 134:336–339

Bauer JW, Schaeppi H, Metze D, Muss W, Pohla-Gubo G, Hametner R, Ruckhofer J, Grabner G, Hintner H (1999) Ocular involvement in IgA-epidermolysis bullosa acquisita. Br J Dermatol 141:887–892

Lee CW (2000) Serum IgA autoantibodies in patients with epidermolysis bullosa acquisita: a high frequency of detection. Dermatology 200:83–84

Edwards S, Wakelin SH, Wojnarowska F, Marsden RA, Kirtschig G, Bhogal B, Black MM (1998) Bullous pemphigoid and epidermolysis bullosa acquisita: presentation, prognosis and immunopathology in 11 children. Pediatr Dermatol 15:184–190

Burke WA et al (1986) Epidermolysis bullosa acquisita in a patient with multiple endocrinopathies syndrome. Arch Dermatol 122:187

Chan L, Woodley DT (1996) Pemphigoid: bullous and cicatricial. In: Lichtenstein LM, Fauci AS (eds) Current therapy in allergy, immunology and rheumatology, 5th edn. Mosby, St. Louis, p 93

Richter BJ, McNutt NS (1979) The spectrum of epidermolysis bullosa acquisita. Arch Dermatol 115:1325

Woodley DT et al (1983) Localization of basement membrane components after dermal–epidermal junction separation. J Invest Dermatol 81:149

Gammon WR et al (1990) Direct immunofluorescence studies of sodium chloride—separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol 22:664

Domloge-Hultsch N, Anhalt GJ, Gammon WR, Lazarova Z, Briggaman R, Welch M, Jabs DA, Huff C, Yancey KB (1994) Antiepiligrin cicatricial pemphigoid: a subepithelial bullous disorder. Arch Dermatol 130:1521–1529

Ceilley E et al (1993) Labeling of fractured human skin with antibodies to BM 600/nicein, epiligrin, kalinin and other matrix components. J Dermatol Sci 5:97

Ghohestani RF, Hudson BG, Claudy A, Uitto J (2000) The α5 chain of Type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency. J Biol Chem 275:16002–16006

Zillikens D et al (2000) Autoantibodies in anti-p200 pemphigoid stain skin lacking laminin 5 and type VII collagen. Br J Dermatol 143:1043

Chen M et al (1997) Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 108:68

Mekori YA et al (1989) Inhibition of delayed hypersensitivity reaction by colchicine: colchicine inhibits interferon-gamma-induced expression of HLA-DR on a epithelial cell line. Clin Exp Immunol 78:230

Crow LL et al (1988) Clearing of epidermolysis bullosa acquisita on cyclosporin A. J Am Acad Dermatol 19:937

Rook AH et al (1990) Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 112:303

Miller JL et al (1995) Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy. Br J Dermatol 133:467

Gordon K et al (1997) Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy. Br J Dermatol 136:415

Bystryn J-C, Jiao D, Natow S (2002) Treatment of pemphigus with intravenous immunoglobulin. J Am Acad Dermatol 47:358–363

Meier F et al (1993) Epidermolysis bullosa acquisita: efficacy of high dose intravenous immunoglobulins. J Am Acad Dermatol 29:334